Delivery Order HHSN261201600005I-75N91018F00003
Award Date 9/17/18
Potential Completion Date 9/16/20
Potential Value $403K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Poland
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poznań, Poland. The contract is valued at $475,433.33 and has an ultimate completion date of September 17, 2018. The contract is part of the Tissue Source Site for Tumor Analysis master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation.</p>
- This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie (Centrum Onkologii) in Poland. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ, with a ceiling value of $336,000.00 and a period of performance ending on September 30, 2014. The contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA)...
- <p>This is a Delivery Order award to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation-type vendor, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The $144,300.00 Firm Fixed Price contract is for Tissue Source Site for Tumor Analysis services, under a parent Master IDIQ vehicle. The place of performance is in Poland, and the completion date was September 16, 2020. No set-aside was used for this award.</p>
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Biopartners, Inc. for the TSS CPTAC DIGITAL MEDICAL IMAGES OF CPTAC BIOSPECIMENS project. The contract has a ceiling value of $12,240.00 and an ultimate completion date of September 17, 2018. It is part of the Tissue Source Site for Tumor Analysis master IDIQ contract. The contract does not have a set-aside designation. The award supports the NCI's Medical Images for CPTAC Biospecimens program.
- <p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
- This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....
- This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...
- This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...